Literature DB >> 9622046

Mixed symptoms and syndromes of anxiety and depression: diagnostic, prognostic, and etiologic issues.

J G Barbee1.   

Abstract

Patients with comorbid symptoms of anxiety and depression are common in clinical practice, and yet they continue to pose a diagnostic and therapeutic challenge to clinicians and researchers alike. This article is intended as a comprehensive review of current knowledge derived from a vast body of clinical research regarding the diagnostic interrelationships of anxiety and depressive disorders at both syndromal and subsyndromal levels. The prognostic implications of comorbidity are also reviewed. Biological linkages between the two disorders are explored, and recent biological theories attempting to explain and integrate the two disorders are presented as well. The article concludes with suggestions for further research.

Entities:  

Mesh:

Year:  1998        PMID: 9622046     DOI: 10.1023/a:1026198512361

Source DB:  PubMed          Journal:  Ann Clin Psychiatry        ISSN: 1040-1237            Impact factor:   1.567


  11 in total

Review 1.  Treating generalised anxiety disorder.

Authors:  Alison Tonks
Journal:  BMJ       Date:  2003-03-29

2.  Maternal drug abuse versus maternal depression: vulnerability and resilience among school-age and adolescent offspring.

Authors:  Suniya S Luthar; Chris C Sexton
Journal:  Dev Psychopathol       Date:  2007

3.  Parent psychopathology and youth internalizing symptoms in an urban community: a latent growth model analysis.

Authors:  Marcy Burstein; Golda S Ginsburg; Hanno Petras; Nicholas Ialongo
Journal:  Child Psychiatry Hum Dev       Date:  2009-08-08

Review 4.  Global cerebral ischemia: synaptic and cognitive dysfunction.

Authors:  Jake T Neumann; Charles H Cohan; Kunjan R Dave; Clinton B Wright; Miguel A Perez-Pinzon
Journal:  Curr Drug Targets       Date:  2013-01-01       Impact factor: 3.465

5.  Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.

Authors:  S L Clark; D E Adkins; K Aberg; J M Hettema; J L McClay; R P Souza; E J C G van den Oord
Journal:  Psychol Med       Date:  2011-11-01       Impact factor: 7.723

6.  Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.

Authors:  D E Adkins; S L Clark; K Åberg; J M Hettema; J Bukszár; J L McClay; R P Souza; E J C G van den Oord
Journal:  Transl Psychiatry       Date:  2012-07-03       Impact factor: 6.222

7.  Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis.

Authors:  Alexandra Prados-Torres; Beatriz Poblador-Plou; Amaia Calderón-Larrañaga; Luis Andrés Gimeno-Feliu; Francisca González-Rubio; Antonio Poncel-Falcó; Antoni Sicras-Mainar; José Tomás Alcalá-Nalvaiz
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

Review 8.  Neuropharmacological effects of Nigella sativa.

Authors:  Farimah Beheshti; Majid Khazaei; Mahmoud Hosseini
Journal:  Avicenna J Phytomed       Date:  2016 Jan-Feb

9.  Factor structure of the Hospital Anxiety and Depression Scale in Japanese psychiatric outpatient and student populations.

Authors:  Tomomi Matsudaira; Hiromi Igarashi; Hiroyoshi Kikuchi; Rikihachiro Kano; Hiroshi Mitoma; Kiyoshi Ohuchi; Toshinori Kitamura
Journal:  Health Qual Life Outcomes       Date:  2009-05-17       Impact factor: 3.186

10.  Potential Antidepressant Constituents of Nigella sativa Seeds.

Authors:  Ehab S Elkhayat; Mohammad S Alorainy; Ibrahim M El-Ashmawy; Shawkat Fat'hi
Journal:  Pharmacogn Mag       Date:  2016-01       Impact factor: 1.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.